COVID-19 trends continue to improve at Geisinger; Phase 1A vaccination proceeds amid global supply constraints
DANVILLE, Pa. – The downward trend in COVID-19 hospitalizations and the virus positivity rate continues throughout Geisinger’s coverage area as thousands more people are vaccinated each day against the virus.
Despite continued positive trends, Geisinger continues to see high COVID-19 activity in central and northeastern Pennsylvania, rivaling levels from mid-November.
- In January, we performed about 41,000 COVID tests, with about 7,000 coming back positive, for a positivity rate of about 17%.
- Over the past two weeks, we’ve averaged about 140 positive COVID-19 tests per day, with an average positivity rate of about 13%.
- This is in comparison to December, when we averaged more than 400 positive tests per day and a positivity rate of 23%.
- This past week, we reached the milestone of having fewer than 150 patients hospitalized with COVID-19, getting as low as 146 earlier this week.
- Patients with COVID-19 make up about 15% of all of our patients admitted to the hospital, which is about half the amount compared to late December.
“These downward trends continue to spark hope in all of us that better days are on the horizon in the fight against COVID-19,” said Jaewon Ryu, M.D., J.D., Geisinger president and chief executive officer. “But that spark can be quickly extinguished if we don’t keep doing everything we can to prevent the virus’ spread. We know that current demand for the COVID vaccine far exceeds supplies in Pennsylvania, the country and the world, meaning it will be quite some time before we can vaccinate enough people to let our guard down with things like masking, distancing and avoiding gatherings.”
Geisinger is continuing to provide vaccines to those in the state’s Phase 1A groups who’ve scheduled appointments at one of its four vaccine centers. Booking for new first-dose COVID vaccines remains temporarily closed as we work through existing appointments over the next several weeks.
- This week Geisinger provided its 69,000th COVID-19 vaccine, about 56,000 of which have been first doses.
- We’ve also now provided more than 13,000 second doses.
- Two-thirds of our employees have received at least one dose of the COVID-19 vaccine, and about half of our employees have received both doses.
- Over that time, we’ve seen the number of employees testing positive decrease by about 90% from a peak in mid-December.
“We continue to work closely with the Pennsylvania Department of Health to understand what vaccine quantities we can expect, and we will administer additional vaccines as supplies and logistics allow,” Ryu said. “It will still take some time to work through Phase 1A, so we ask for everyone’s patience until the vaccine supply catches up to the demand across the country.”
For the latest information on Geisinger’s vaccination efforts, and for answers to your questions about the vaccine, please visit geisinger.org/COVIDvax regularly. If you or a loved one has an upcoming vaccine appointment, please ensure your patient contact information is current in MyGeisinger to ensure Geisinger representatives can reach you in the event of an appointment postponement due to severe weather or any unforeseen circumstance.
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.